The determination of hormone receptors in tumor tissue samples today is accepted as a necessary step with in a selective treatment plan for patients with breast cancer. The following way discussed our clinical knowledge about hormone receptors in breast cancer. Besides a therapy concept for metastatic breast cancer an adjuvant treatment trial for stage II breast cancer patients based on the estrogen receptor status will be presented.